This Week's Poll

At the recent BioPartner Forum it was stated the internal market is insufficient for a UK Life Science company to develop a technology, product or service at a rate that will return investor value. Do you

Supported by Medilink UK

Regulation for export - John Adcock of - Advena Medical - 8:56:49am Jan-28th

UK SMEs operating in the medical diagnostics industry want to compete with the global companies yet often need a reminder about the importance of regulatory issues. A word of advice: appropriate risk management approval processes may protect you from future liability issues, so make sure your documentation is detailed and conforms to the European standards.

Agree/Disagree + add comment
Thumbs Up1 person agrees with this
 
 
t